Paula M. Lantz, PhD, MS is professor and associate dean for academic affairs at the Gerald R. Ford School of Public Policy and professor of health management and policy in the School of Public Health at the University of Michigan. As a social demographer/epidemiologist, Dr. Lantz’s research focuses on public health policy and upstream social policies that address population health issues and health disparities. Current research projects focus on policy issues related to clinical preventive services, and the potential for social impact bonds/Pay for Success projects to address social determinants of health and reduce health care costs in Medicaid populations. Dr. Lantz is an elected member of the National Academy of Medicine.
Paula Lantz and Samantha Iovan of the University of Michigan Research Hub used their innovative pay-for-success (PFS) surveillance system to identify strengths and challenges of several supportive housing interventions using PFS, and to assess whether PFS housing projects generally meet established criteria for improving social welfare.
Steven H. Goldberg, Paula M. Lantz, and Samantha Iovan from the University of Michigan P4A Research Hub examine the use of federal Medicaid dollars as a payout source for non-medical services aimed at addressing social determinants of health under the 2016 Medicaid Managed Care Final Rule.
The Pay for Success model may prove to be a valuable tool for increasing critical investments in effective health and wellness interventions. The public-private nature of the approach can encourage important ties between the business community, investment groups, philanthropy, and public agencies and service systems; and stimulate innovative changes in the financing and delivery of sustainable, community-driven solutions.
What kind of cost savings could be achieved if a "Pay for Success" (PFS) financing model were applied to a home-based, multi-component asthma intervention among low-income children on Medicaid in Detroit? The University of Michigan Research Hub team found that the economics of a PFS intervention are most viable if it targets children who have already experienced an expensive episode of asthma-related care.